Best Iclusig (Ponatinib) Medicine in India

Iclusig (Ponatinib) is a targeted anticancer medicine used to treat certain types of Philadelphia chromosome-positive (Ph+) leukemia, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It is particularly used in patients with certain BCR::ABL1 mutations, including the T315I mutation, or when other tyrosine kinase inhibitor treatments are not suitable. Ponatinib works by blocking abnormal BCR::ABL1 signaling that promotes the growth and survival of leukemia cells.

Iclusig (Ponatinib) should be taken exactly as prescribed by your doctor. It may be taken with or without food. Swallow the tablet whole with water and do not crush, chew, or break it. The dose and treatment duration depend on your condition, previous treatments, and response to therapy. Regular blood tests and medical check-ups may be required to monitor blood counts, liver function, blood pressure, and treatment response.

Common side effects of Iclusig (Ponatinib) may include constipation, skin rash, abdominal pain, headache, dry skin, fatigue, joint or muscle pain, and increased blood pressure. Ponatinib can also cause serious blood vessel problems, blood clots, heart problems, liver problems, and pancreatitis. Inform your doctor promptly if you develop chest pain, shortness of breath, severe abdominal pain, sudden weakness or numbness, difficulty speaking, or other unusual symptoms. Before starting treatment, tell your doctor about any history of heart disease, blood clots, high blood pressure, liver problems, or other medical conditions. Inform your healthcare team about all medicines, vitamins, herbal products, and dietary supplements you are taking, as some may interact with Ponatinib.

Treatment of Philadelphia Chromosome-Positive Leukemia

Iclusig (Ponatinib) is used to treat certain adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), including cancers with the T315I BCR::ABL1 mutation or cases where other tyrosine kinase inhibitors are not suitable. It blocks abnormal BCR::ABL1 signaling, helping to inhibit the growth and survival of leukemia cells and slow disease progression.

Some side effects of Iclusig (Ponatinib) may improve as your body adjusts to the medicine. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Iclusig (Ponatinib)

Iclusig (Ponatinib) should be taken exactly as prescribed by your doctor. It may be taken with or without food. Swallow the tablet whole with water and do not crush, chew, or break it. Take it at the same time each day as advised. Do not change the dose or stop treatment without consulting your doctor.

Iclusig (Ponatinib) is a targeted therapy that blocks the abnormal BCR::ABL1 tyrosine kinase responsible for the growth and survival of certain leukemia cells. It can also act against certain resistant BCR::ABL1 mutations, including the T315I mutation. By blocking these signals, Ponatinib helps prevent leukemia cells from growing and multiplying and may slow the progression of Ph+ CML and Ph+ ALL.

• Keep the tablets at a controlled room temperature of 20°C to 25°C.
• Temporary temperature variations between 15°C and 30°C are permitted.
• Store the medicine in its original container and protect it from unsuitable storage conditions.
• Keep Iclusig in a secure place away from the reach of children.

Alcohol CONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Iclusig (Ponatinib).

Pregnancy CONSULT YOUR DOCTOR

Iclusig (Ponatinib) may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception as advised by your doctor.

Breastfeeding CONSULT YOUR DOCTOR

Do not breastfeed during treatment with Iclusig (Ponatinib) and for the recommended period after the final dose. Consult your doctor for guidance.

Driving CONSULT YOUR DOCTOR

Iclusig (Ponatinib) may cause dizziness, fatigue, or vision problems. Avoid driving if these symptoms affect your ability to drive safely.

Kidney CAUTION

Inform your doctor if you have kidney problems before starting treatment. Your doctor may monitor kidney function during therapy.

Liver CAUTION

Tell your doctor if you have liver disease. Ponatinib can affect liver function, so your doctor may perform regular liver function tests.

• Take Iclusig (Ponatinib) exactly as prescribed and do not change or stop treatment without your doctor's advice.
• Attend regular blood tests and medical check-ups to monitor blood counts, liver function, blood pressure, and treatment response.
• Contact your doctor immediately if you experience chest pain, shortness of breath, sudden weakness, numbness, difficulty speaking, or severe headache.
• Report severe abdominal pain, unusual bleeding, dark urine, or yellowing of the skin or eyes promptly.
• Inform your doctor about all medicines, vitamins, herbal products, and dietary supplements you are taking to help prevent possible drug interactions.
• Read More About - Iclusig (Ponatinib) from Pharma Five.

Pharma Five, can support patients in importing Iclusig (Ponatinib) in small quantities for personal use. The applicant is required to submit an application in Form 12A along with a prescription provided by a Registered Medical Practitioner (RMP).

Pharma Five supports patients requiring Iclusig (Ponatinib) by offering professional pharmaceutical consultancy and facilitation services for accessing specialized products through import procedures. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.